It was reported that the dual activities of Aβ clearance and reactive oxygen species (ROS) scavenging nanoparticles exhibited improved cognitive functions in APP/PS1 transgenic mice, which might be potential therapeutic strategy in AD treatments (Zhang et al. 2024). The gene discussed is APP; the disease is Alzheimer disease.